At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 54 enrolled
Drug / intervention
acyclovir/hydrocortisone creamdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
In Brief
A Phase 3 clinical trial evaluating acyclovir/hydrocortisone cream for Herpes Labialis. Completed, enrolled 54 participants across 10 sites.
Detailed Summary
To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHerpes Labialis
CountriesUnited States
CollaboratorsTKL Research, Inc.
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedApr 2012
Primary CompletionDec 2012
Study CompletionFeb 2013
TodayJul 2026
First PostedApr 10, 2012
Enrollment StartMar 1, 2012
Primary CompletionDec 1, 2012
Study CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.2 years ago
Interventions
acyclovir/hydrocortisone creamdrug
cream applied topically to lesion five times daily for five days